A closer look at resistant hypertension for American Heart Month

Did you know that February is American Heart Month? This month is dedicated to raising awareness for and providing education on heart health, high blood pressure, and cardiovascular disease.

Continue reading

Trends in the medical research space: Reflections from SCOPE 2023

The Summit for Clinical Ops Executives (known as SCOPE), is one of the year’s largest conferences focused on clinical research — and one the Antidote team was thrilled to attend in 2023.

Continue reading

How long do clinical trial phases take?

Before any new medication, treatment, or therapy can be administered to patients, it must progress through the proper clinical trial phases, which are designed to test the drug or device in question for safety and effectiveness. This process can take a long time — in most cases, an average of 10 years will pass between initial discovery to full approval, with the clinical trial stages taking six ...

Continue reading

Antidote's curated journey capabilities [one-pager]

When matching individuals to medical research opportunities, patient centricity is at the heart of the process for Antidote. Through our best-in-class clinical trial matching software, we provide a streamlined, user-friendly experience for any individual searching for a trial — and now, through our curated journeys, we’re able to refine this process even more.

Continue reading

How Antidote uses database insights to drive lupus research [whitepaper]

Lupus is a chronic autoimmune disease that causes the body to attack its own tissues and organs. For the 1.5 million people in the United States that live with the disease, it has severe implications — symptoms include pain, fatigue, hair loss, cognitive issues, physical impairments, and disfiguring rashes. An estimated 10-15% of lupus patients will die prematurely due to the condition.

Continue reading

COPD resources: Where to find the information and support you need

Chronic obstructive pulmonary disease, known commonly as COPD, is a condition that impacts more than 16 million Americans. COPD is a chronic, inflammatory lung disease that obstructs the airflow to and from the lungs, and common symptoms include a continual cough, shortness of breath, excess mucus, and chest tightness.For those living with COPD, their loved ones, and their care partners, we’re ...

Continue reading

Antidote Technologies and XpertPatient partner to empower newly-diagnosed cancer patients to take part in clinical research

We’re excited to share that today, we announced a partnership with XpertPatient, an award-winning educational website that provides support to newly-diagnosed cancer patients. We are providing the XpertPatient community with access to Antidote Match™, our patient-friendly clinical trial search that currently powers clinical trial matching for 300+ patient organizations.

Continue reading

7 clinical trial patient recruitment and retention tips

Clinical trial patient recruitment is a major challenge in the industry — 85% of trials fail to recruit enough patients, 80% are delayed due to recruitment problems, and dropout rates soar. Both at the recruitment and retention stages, taking a patient-centric approach to clinical trial design is a must in order to set your trial up for success.

Continue reading

Talk of the Towne episode 06: XpertPatient

Talk of the Towne is a podcast from Antidote focused on that special place where science and patients converge. It’s hosted by Richard Towne, PharmD, Antidote’s Senior Clinical Informatics Manager. Each episode, Talk of the Towne features a new guest from an Antidote partner organization, and takes an in-depth look at particular therapeutic areas, zeroing in on the story that our data is telling ...

Continue reading

World Cancer Day cancer research roundup

The statistics about the prevalence of cancer can be disheartening. Over 10 million people die each year from cancer, making it one of the leading causes of death — and unfortunately, researchers have yet to find a cure for many cancers.

Continue reading

Get our latest posts in your inbox